Welcome

Welcome to the 'Oxford Innovative Organic Synthesis for Cancer Research (OxIOSCR)' project, an EU-funded Marie Curie Innovative Doctoral Programme (IDP), established to train graduate organic chemists to develop synthetic routes to natural products and their analogues with potent anti-cancer activity.
Chemistry equipment
Thirteen doctoral research students, Early Stage Researchers (ESRs), are undertaking a three-year comprehensive training programme, working within the Department of Chemistry at the University of Oxford, using state-of-the-art synthetic methods and techniques with a particular focus on biocatalysis, electrosynthesis and flow chemistry. The ESRs are working in teams of three or four on distinct programmes of research supported by expert chemistry and cancer biology advisers. While largely being based within Oxford's research environment, the ESRs, during their second year of training, will be posted on two one-month secondments hosted by eight Associated Partners distributed over six European countries.

Stacks Image 5544
The overarching aim of the OxIOSCR training programme is to lead to more sustainable synthetic chemistry, new strategies for organic synthesis, a strongly connected network of chemists and cancer biologists and release a generation of fully trained synthesis innovators into the academic and chemical industrial workplace.

Recent highlights

Publications (May 2016): Congratulations Laia Josa Culleré on her two recent publications in the Journal of Organic Chemistry and SynLett. Read more...
Poster prize win (Mar 2016): Aubert Ribaucourt has been awarded the Chemistry World poster prize at ISACS19: Challenges in Organic Chemistry. Read more...
Student news (Feb 2016). Running to succeed: Aubert Ribaucourt is running the London Marathon for Spinal Research... Read more...
World Cancer Day - tours of the CRL (4th February 2016): World Cancer Day visitors - news and resources from the event. Read more...Gallery...News...
Stacks Image 1536
This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement number: 316955.